Your browser doesn't support javascript.
loading
Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models.
Han, Lina; Zhang, Qi; Dail, Monique; Shi, Ce; Cavazos, Antonio; Ruvolo, Vivian R; Zhao, Yang; Kim, Eugene; Rahmani, Mohamed; Mak, Duncan H; Jin, Sha S; Chen, Jun; Phillips, Darren C; Koller, Paul Bottecelli; Jacamo, Rodrigo; Burks, Jared K; DiNardo, Courtney; Daver, Naval; Jabbour, Elias; Wang, Jing; Kantarjian, Hagop M; Andreeff, Michael; Grant, Steven; Leverson, Joel D; Sampath, Deepak; Konopleva, Marina.
Affiliation
  • Han L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zhang Q; Department of Hematology, First Affiliated Hospital, Harbin Medical University, Harbin, China.
  • Dail M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Shi C; Department of Oncology Biomarkers, Genentech, South San Francisco, CA, USA.
  • Cavazos A; Department of Hematology, First Affiliated Hospital, Harbin Medical University, Harbin, China.
  • Ruvolo VR; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zhao Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kim E; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rahmani M; Department of Oncology Biomarkers, Genentech, South San Francisco, CA, USA.
  • Mak DH; College of Medicine, Sharjah Institute for Medical Research, University of Sharjah, Sharjah, UAE.
  • Jin SS; Division of Hematology/Oncology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA.
  • Chen J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Phillips DC; AbbVie Inc., North Chicago, IL, USA.
  • Koller PB; AbbVie Inc., North Chicago, IL, USA.
  • Jacamo R; AbbVie Inc., North Chicago, IL, USA.
  • Burks JK; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • DiNardo C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Andreeff M; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Grant S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Leverson JD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sampath D; Division of Hematology/Oncology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA.
  • Konopleva M; AbbVie Inc., North Chicago, IL, USA.
Haematologica ; 105(3): 697-707, 2020 03.
Article in En | MEDLINE | ID: mdl-31123034
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Proteomics Limits: Humans Language: En Journal: Haematologica Year: 2020 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Proteomics Limits: Humans Language: En Journal: Haematologica Year: 2020 Type: Article Affiliation country: United States